It’s big news at Matcher ! We are delighted to announce that Matcher Technologies Ltd has received significant growth investment from ReproTech LLC – the US-based specialist in cryostorage technology solutions.
We’re extremely excited about this partnership, especially as both organisations share a like-minded commitment to exceptional service, continuous innovation, high-quality outputs, and a strong focus on growth.
This growth will be underlined by our complimentary products – with Matcher’s witnessing and traceability system which extends into IVF centres’ on-site cryostorage; through to ReproTech’s cryo-management system and into their logistics and transportation system and finally to off-site storage at their purpose-built biorepositories. The partnership marks a significant step towards building the first truly comprehensive platform to digitally document every step of the IVF process – eliminating pain-points and delivering a seamless and streamlined experience.
So, what’s going to change ? The short answer is nothing. In fact, not only is it business as usual, but it’s foot on the gas, as we are keen to take advantage of the growing demand from fertility centres and donor banks around the world. They are realising that manual witnessing can no longer be defended, and that competitors in the market don’t bring the 20 years of focussed expertise and excellence to their products that we do.
We remain fully committed to delivering exceptional service and support to our existing end users and combined with the accelerated innovation this partnership brings, we see strong potential for added value through additional global time-zone support, enhanced features, new integrations, and a more agile product release roadmap.
And as to how the day-to-day will look, Matcher will operate as a distinct subsidiary within ReproTech’s broader business, and operations from its UK headquarters will continue unchanged. George Heywood remains CEO of Matcher and taken on additional responsibilities as Chief Technology Officer and VP of International Operations at ReproTech. The rest of the team remain the same, with the same products, the same processes and the same distributors.
Brad Senstra of ReproTech commented, “We are certainly thrilled to welcome Matcher into the ReproTech family – the teams, technologies, mission and values align perfectly with ours, and we see Matcher as an integral part of ReproTech’s continuing growth and geographic expansion.”
From Matcher’s perspective, ReproTech’s reputation as a trusted cryostorage solutions partner—with over 35 years of experience—and their dedication to advancing traceability in fertility care make them an ideal partner. Together, we can drive innovation and enhance our service offerings in both domestic and international markets.
We can’t wait to move into this new era with you and please let us know if you have any questions.
View George and Brad’s announcement video
Matcher Technologies Ltd was advised by Clearwater, Brabners LLP, and Claritas Tax. ReproTech was advised by Shoosmiths LLP, BDO LLP, and Armstrong Teasdale LLP.

George Heywood, CEO of IMT Matcher and Brad Senstra, CEO of ReproTech are excited to get started on their combined journey of providing the highest quality, safest and most compliant products for their clinic partners.
Contact
Matcher Technologies Ltd
1b Canalside Business Park
Tattenhall
Chester
CH3 9BD
United Kingdom
Tel: +44(0)1829 771 327
Email: info@imtmatcher.com
Additional Information
Copyright
Copyright © 2002-2025 Matcher Technologies Ltd.